Petroni, Giulia
Weill Cornell Medicine
6 papers on CoChatORCID 0000-0002-0558-5322
Most cited papers
- Verified
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal
Autophagy in Disease and TherapyUbiquitin and proteasome pathways
Cited by 1,585
- Verified
Detection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease
Immunotherapy and Immune ResponsesCell death mechanisms and regulation
Cited by 1,138
- Verified
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
Yamazaki, T., Kirchmair, A., Sato, A., Buqué, A., Rybstein, M., Petroni, G., Bloy, N., Finotello, F., Stafford, L., Navarro Manzano, E., et al. (2020) · Nature Immunology
Autophagy in Disease and TherapyCancer Immunotherapy and Biomarkers
Cited by 359
- Verified
Immunomodulation by targeted anticancer agents
Petroni, G., Buqué, A., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2021) · Cancer Cell
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 212
- Verified
Immunomodulation by anticancer cell cycle inhibitors
Petroni, G., Formenti, S. C., Chen-Kiang, S., & Galluzzi, L. (2020) · Nature Reviews Immunology
Cancer Immunotherapy and BiomarkersAdvanced Breast Cancer Therapies
Cited by 163
- Verified
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients
Rodriguez-Ruiz, M. E., Buqué, A., Hensler, M., Chen, J., Bloy, N., Petroni, G., Sato, A., Yamazaki, T., Fucikova, J., & Galluzzi, L. (2019) · OncoImmunology
Cell death mechanisms and regulationCancer Immunotherapy and Biomarkers
Cited by 147
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free